In March 2025, the company introduced new designs for any direct-to-purchaser offering of its Wegovy weight loss drug. The company founded a brand new pharmacy, named NovoCare, which might cost customers $499 per month for usage of the drug, less than half the price of the drug by way of other pharmaceutical distribution networks.[53]Include these